Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
193
-
Total 13F shares, excl. options
-
82.5M
-
Shares change
-
+13.8M
-
Total reported value, excl. options
-
$211M
-
Value change
-
+$33.6M
-
Put/Call ratio
-
2.19
-
Number of buys
-
100
-
Number of sells
-
-62
-
Price
-
$2.56
Significant Holders of ImmunityBio, Inc. - COM (IBRX) as of Q4 2024
234 filings reported holding IBRX - ImmunityBio, Inc. - COM as of Q4 2024.
ImmunityBio, Inc. - COM (IBRX) has 193 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82.5M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (17.3M shares), BlackRock, Inc. (13.6M shares), STATE STREET CORP (9.79M shares), MORGAN STANLEY (4.01M shares), GEODE CAPITAL MANAGEMENT, LLC (3.84M shares), Woodline Partners LP (3.44M shares), Cormorant Asset Management, LP (3M shares), TANG CAPITAL MANAGEMENT LLC (2.81M shares), UBS Group AG (1.59M shares), and NORTHERN TRUST CORP (1.32M shares).
This table shows the top 193 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.